Uddin Zia, Maennle Diane, Russell Kimberly, Boltri John M
Northeast Ohio Medical University, Rootstown, OH, USA.
Northeast Ohio Medical University, Rootstown, OH, USA. Email:
J Fam Pract. 2015 Jul;64(7):E5-E12.
Varying combinations of 3 measurable factors determine a patient's risk of progressing toward multiple myeloma and influence monitoring decisions. This review--and accompanying algorithm--can guide your approach. For monoclonal gammopathy of undetermined significance (MGUS) patients at low risk, repeat serum protein electrophoresis (SPE) in 6 months. If no significant elevation of M-protein is found, repeat SPE every 2 to 3 years.
3个可测量因素的不同组合决定了患者发展为多发性骨髓瘤的风险，并影响监测决策。本综述及随附的算法可指导你的治疗方法。对于低风险意义未明的单克隆丙种球蛋白病（MGUS）患者，在6个月时重复进行血清蛋白电泳（SPE）。如果未发现M蛋白显著升高，则每2至3年重复进行一次SPE。
